Optiver Holding
BCRX icon

Optiver Holding’s BioCryst Pharmaceuticals BCRX Stock Holding History

Optiver Holding’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88K Sell
302
-181
-37% -$1.41K ﹤0.01% 1688
2025
Q4 		$3.77K Sell
483
-807
-63% -$5.83K ﹤0.01% 1575
2025
Q3 		$9.79K Sell
1,290
-4,292
-77% -$35.7K ﹤0.01% 1316
2025
Q2 		$50K Buy
5,582
+5,073
+997% +$47.2K ﹤0.01% 621
2025
Q1 		$3.82K Buy
509
+460
+939% +$3.71K ﹤0.01% 1147
2024
Q4 		$368 Buy
+49
New +$372 ﹤0.01% 1014
2024
Q3 		– Sell
-936
Closed -$5.78K – 953
2024
Q2 		$5.78K Buy
+936
New +$5.17K ﹤0.01% 782

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return